Research Paper Volume 16, Issue 17 pp 12335—12345
Treatment of tumor-associated macrophages with PD-1 monoclonal antibodies affects vascular generation in cervical cancer via the PD-1/IRE1α/SHP2/HIF1α signaling pathway
Figure 5. Impact of PD-1 monoclonal antibodies in TAMs on the angiogenic ability of cervical cancer cells. (A) H&E staining results graph and statistical graph of blood vessel numbers; (B) angiogenesis experimental results and vessel count statistics of Hela cells and C33A cells. Data were expressed as mean±SD. *P<0.05; nsP>0.05.